In support of this hypothesis, it has been demonstrated that pharmacological stimulation of cortical and hippocampal axonal regrowth in transgenic mice co-expressing multiple AD-related mutations, is dependent upon the activation of PDIA3, which results in an overall reduction of AD neuropathology and increased performance in object recognition tasks in these murine models [36]. Here, PDIA3 is linked to Alzheimer disease.